In breast cancer (BC) patients treated with anthracyclines-based therapies, we aim at assessing whether adjuvant drugs impact cardiac function differently and whether their cardiotoxicity has a regional pattern.
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC) / Zito, Concetta; Manganaro, Roberta; Cusmà Piccione, Maurizio; Madonna, Rosalinda; Monte, Ines; Novo, Giuseppina; Mercurio, Valentina; Longobardo, Luca; Cadeddu Dessalvi, Christian; Deidda, Martino; Pagliaro, Pasquale; Spallarossa, Paolo; Costantino, Rossella; Santarpia, Mariacarmela; Altavilla, Giuseppe; Carerj, Scipione; Tocchetti, Carlo Gabriele. - In: EUROPEAN HEART JOURNAL. CARDIOVASCULAR IMAGING. - ISSN 2047-2404. - (2021). [10.1093/ehjci/jeaa339]
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC)
Mercurio, Valentina;Pagliaro, Pasquale;Tocchetti, Carlo Gabriele
2021
Abstract
In breast cancer (BC) patients treated with anthracyclines-based therapies, we aim at assessing whether adjuvant drugs impact cardiac function differently and whether their cardiotoxicity has a regional pattern.| File | Dimensione | Formato | |
|---|---|---|---|
|
2021 zito jeaa339.pdf
solo utenti autorizzati
Licenza:
Accesso privato/ristretto
Dimensione
490.72 kB
Formato
Adobe PDF
|
490.72 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
